3 unknown. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 3 |
Follow SCTV01E: new trials by email Literature Review of SCTV01E trials Research Report on SCTV01E
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase III Clinical Trial to Evaluate the Efficacy and Safety of SCTV01E in Healthy People CoronaVac, SCTV01E - COVID-19 SARS-CoV-2 Infection | Phase 3 | Unknown | Sinocelltech Ltd. | 6000 | 2023-01-25 | 2023-01-13 |
| A Study to Evaluate the Efficacy and Safety of SCTV01E (a COVID-19 Vaccine) in Population Aged ≥18 Years SCTV01E, Placebo - COVID-19, SARS-CoV-2 Infection | Phase 3 | Unknown | Sinocelltech Ltd. | 10000 | 2022-12-26 | 2024-04-15 |
| A Study to Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster Vaccines SCTV01C, SCTV01E, Sinopharm inactivated COVID-19 vaccine - COVID-19, SARS-CoV-2 Infection | Phase 3 | Unknown | Sinocelltech Ltd. | 1800 | 2022-05-30 | 2023-04-10 |
COVID-19 (2)
China (1) · United Arab Emirates (1)
Yu Sun (1)